Most importantly, no information is currently available with respect to specific ABCA1- and ABCG1-CEC or on HDL remodeling serum enzymes activity in AAA patients compared to a control population with the same serum lipid profile and cardiovascular disease burden. This evidence concerns the gene ABCG1 and triple-A syndrome.